Pluripotent stem cells in disease modelling and drug discovery

Experimental modelling of human disorders enables the definition of the cellular and molecular mechanisms underlying diseases and the development of therapies for treating them. The availability of human pluripotent stem cells (PSCs), which are capable of self-renewal and have the potential to differentiate into virtually any cell type, can now help to overcome the limitations of animal models for certain disorders. The ability to model human diseases using cultured PSCs has revolutionized the ways in which we study monogenic, complex and epigenetic disorders, as well as early- and late-onset diseases. Several strategies are used to generate such disease models using either embryonic stem cells (ES cells) or patient-specific induced PSCs (iPSCs), creating new possibilities for the establishment of models and their use in drug screening.

[1]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[2]  O. Yanuka,et al.  Human Embryonic Stem Cells as Models for Aneuploid Chromosomal Syndromes , 2010, Stem cells.

[3]  T. Ulbright.  Gonadal Teratomas: A Review and Speculation , 2004, Advances in anatomic pathology.

[4]  Morgan L. Maeder,et al.  Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. , 2014, Cell stem cell.

[5]  H. Okano,et al.  [Modeling familial Alzheimer's disease with induced pluripotent stem cells]. , 2012, Rinsho shinkeigaku = Clinical neurology.

[6]  Kristopher L. Nazor,et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.

[7]  Randall J. Platt,et al.  Therapeutic genome editing: prospects and challenges , 2015, Nature Medicine.

[8]  O. Yanuka,et al.  Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. , 2007, Cell stem cell.

[9]  J. Peters.  The role of genomic imprinting in biology and disease: an expanding view , 2014, Nature Reviews Genetics.

[10]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[11]  C. Chen,et al.  Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells , 2014, Nature Communications.

[12]  M. Guillermier,et al.  High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes , 2013, Stem cells.

[13]  Kevin Eggan,et al.  Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model , 2007, Nature Neuroscience.

[14]  Ludovic Vallier,et al.  Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. , 2010, The Journal of clinical investigation.

[15]  O. Yanuka,et al.  Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells , 2011, Nature Structural &Molecular Biology.

[16]  M. Schuldiner,et al.  Modeling for Lesch‐Nyhan Disease by Gene Targeting in Human Embryonic Stem Cells , 2004, Stem cells.

[17]  R. Hamlin,et al.  Extrapolation from mouse to man. , 2011, Circulation. Cardiovascular imaging.

[18]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[19]  A. Urbach,et al.  Comparing ESC and iPSC—Based Models for Human Genetic Disorders , 2014, Journal of clinical medicine.

[20]  D. Pei,et al.  Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome* , 2010, The Journal of Biological Chemistry.

[21]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[22]  C Maayan,et al.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. , 2001, American journal of human genetics.

[23]  S. Monti,et al.  Induced Pluripotent Stem Cell Modeling of Multisystemic, Hereditary Transthyretin Amyloidosis , 2013, Stem cell reports.

[24]  Kristopher L. Nazor,et al.  Epigenetic therapy for Friedreich ataxia , 2014, Annals of neurology.

[25]  Nobutaka Hattori,et al.  Cerebral organoids model human brain development and microcephaly , 2014, Movement disorders : official journal of the Movement Disorder Society.

[26]  N. Benvenisty,et al.  Genome maintenance in pluripotent stem cells , 2014, The Journal of cell biology.

[27]  Blake Byers,et al.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.

[28]  Jeffry D Sander,et al.  Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins , 2013, Nature Biotechnology.

[29]  R. Pedersen,et al.  Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. , 2007, Human molecular genetics.

[30]  S. Rehen,et al.  Altered Oxygen Metabolism Associated to Neurogenesis of Induced Pluripotent Stem Cells Derived from a Schizophrenic Patient , 2012, Cell transplantation.

[31]  James Adjaye,et al.  Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer’s disease donor as a model for investigating AD-associated gene regulatory networks , 2015, BMC Genomics.

[32]  G. Kelsey,et al.  Detailed Analysis of the Genetic and Epigenetic Signatures of iPSC-Derived Mesodiencephalic Dopaminergic Neurons , 2014, Stem cell reports.

[33]  J. Rinn,et al.  Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells , 2015, Nature Genetics.

[34]  A. Schambach,et al.  Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. , 2012, Human molecular genetics.

[35]  C. Svendsen,et al.  Inhibition of Apoptosis Blocks Human Motor Neuron Cell Death in a Stem Cell Model of Spinal Muscular Atrophy , 2012, PloS one.

[36]  K. Hochedlinger,et al.  Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. , 2013, Cell stem cell.

[37]  G. Ananiev,et al.  Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. , 2014, Human molecular genetics.

[38]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[39]  David I. Wilson,et al.  Molecular Genetics of Early Human Development , 1997 .

[40]  S. Finkbeiner,et al.  Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models , 2014, Nature chemical biology.

[41]  M. Pandolfo,et al.  Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia. , 2015, Human molecular genetics.

[42]  Stormy J. Chamberlain,et al.  Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1 , 2014, Molecular Autism.

[43]  L. Rubin,et al.  A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. , 2013, Cell stem cell.

[44]  Rudolph E. Tanzi,et al.  Effect of potent γ-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers. , 2014, JAMA neurology.

[45]  N. Turovets,et al.  Patient-specific stem cell lines derived from human parthenogenetic blastocysts. , 2007, Cloning and stem cells.

[46]  Y. Cho,et al.  A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation , 2015, The Journal of pathology.

[47]  F. Endo,et al.  HPGCD Outperforms HPBCD as a Potential Treatment for Niemann‐Pick Disease Type C During Disease Modeling with iPS Cells , 2015, Stem cells.

[48]  N. Benvenisty,et al.  Studying Early Lethality of 45,XO (Turner's Syndrome) Embryos Using Human Embryonic Stem Cells , 2009, PloS one.

[49]  Bon-Kyoung Koo,et al.  Modeling mouse and human development using organoid cultures , 2015, Development.

[50]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[51]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[52]  C. Mummery,et al.  Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease , 2012, Circulation.

[53]  Alessandra Giorgetti,et al.  Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[54]  Yoav Mayshar,et al.  Clone‐ and Gene‐Specific Aberrations of Parental Imprinting in Human Induced Pluripotent Stem Cells , 2009, Stem cells.

[55]  N. Benvenisty,et al.  Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. , 2012, Journal of molecular cell biology.

[56]  P. Devroey,et al.  Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. , 2006, Human reproduction.

[57]  A. del Sol,et al.  Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs , 2014, Nature Communications.

[58]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[59]  Stormy J. Chamberlain,et al.  Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs. , 2014, Human molecular genetics.

[60]  Michael D. Pluth,et al.  Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons , 2013, Science.

[61]  Larissa A. Haliw,et al.  Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. , 2014, Human molecular genetics.

[62]  H. Vinters,et al.  Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease , 2014, Science Translational Medicine.

[63]  N. Wald,et al.  Fetal loss in Down syndrome pregnancies , 1999, Prenatal diagnosis.

[64]  J. Takahashi,et al.  Modeling the Early Phenotype at the Neuromuscular Junction of Spinal Muscular Atrophy Using Patient-Derived iPSCs , 2015, Stem cell reports.

[65]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[66]  P. Leder,et al.  Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. , 1998, Genes & development.

[67]  Robert H. Brown,et al.  Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. , 2014, Cell reports.

[68]  P. W. Verco,et al.  Turner's syndrome. , 1986, Australasian radiology.

[69]  David A. Orlando,et al.  Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. , 2013, Cell stem cell.

[70]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[71]  H. Hioki,et al.  Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.

[72]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[73]  V. Sybert,et al.  Turner's syndrome. , 1996, The New England journal of medicine.

[74]  Steven D. Edland,et al.  Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. , 2015, Cell stem cell.

[75]  Hans Clevers,et al.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.

[76]  Hans Clevers,et al.  A functional CFTR assay using primary cystic fibrosis intestinal organoids , 2013, Nature Medicine.

[77]  Tamas L. Horvath,et al.  Modeling human cortical development in vitro using induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[78]  S. Ge,et al.  Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC‐Derived Human Neurons , 2015, Stem cells.

[79]  N. Benvenisty,et al.  Involvement of parental imprinting in the antisense regulation of onco-miR-372-373 , 2013, Nature Communications.

[80]  S. Yamanaka,et al.  A decade of transcription factor-mediated reprogramming to pluripotency , 2016, Nature Reviews Molecular Cell Biology.

[81]  James A. Thomson,et al.  Homologous recombination in human embryonic stem cells , 2003, Nature Biotechnology.

[82]  T. Bouwmeester,et al.  High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome , 2015, Journal of biomolecular screening.

[83]  Michael F. Walker,et al.  Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons , 2014, Molecular Psychiatry.

[84]  S. Rehen,et al.  Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells , 2014, Schizophrenia Research.

[85]  Kevin Eggan,et al.  From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial. , 2015, Cell stem cell.

[86]  M. Cuccaro,et al.  Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells , 2012, Neuroscience Letters.

[87]  John R. Yates,et al.  Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.

[88]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[89]  F. Urano,et al.  A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome , 2014, Proceedings of the National Academy of Sciences.

[90]  C. Mummery,et al.  International Coordination of Large-Scale Human Induced Pluripotent Stem Cell Initiatives: Wellcome Trust and ISSCR Workshops White Paper , 2014, Stem cell reports.

[91]  G. Daley,et al.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. , 2010, Blood.

[92]  H. Kim,et al.  Pathological roles of the VEGF/SphK pathway in Niemann–Pick type C neurons , 2014, Nature Communications.

[93]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[94]  N. Benvenisty,et al.  Quality control Genome maintenance in pluripotent stem cells , 2014 .

[95]  D. Krainc,et al.  Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.

[96]  R. Dolmetsch,et al.  SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients , 2013, Nature.

[97]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[98]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[99]  Jun S. Song,et al.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.

[100]  Fred H. Gage,et al.  Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.

[101]  N. Benvenisty,et al.  Cell Lines Derived from Human Parthenogenetic Embryos Can Display Aberrant Centriole Distribution and Altered Expression Levels of Mitotic Spindle Check-point Transcripts , 2009, Stem Cell Reviews and Reports.

[102]  W. V. van Roon-Mom,et al.  Antisense oligonucleotides in therapy for neurodegenerative disorders. , 2015, Advanced drug delivery reviews.

[103]  Ji Young Kim,et al.  Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients , 2011, Annals of neurology.

[104]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[105]  A. Ferguson-Smith,et al.  Genomic imprinting: the emergence of an epigenetic paradigm , 2011, Nature Reviews Genetics.

[106]  G. Daley,et al.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.

[107]  M. Pellegrini,et al.  Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells. , 2014, Human molecular genetics.

[108]  K. Eggan,et al.  Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. , 2008, Cell stem cell.

[109]  Yonatan Stelzer,et al.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome , 2014, Nature Genetics.

[110]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[111]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[112]  Katsuhiro Yoshikawa,et al.  Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. , 2013, Cell stem cell.

[113]  M. Eiraku,et al.  Self-organizing optic-cup morphogenesis in three-dimensional culture , 2011, Neuroscience Research.

[114]  M. Shamloo,et al.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. , 2013, The Journal of clinical investigation.

[115]  QingYun Mai,et al.  Derivation of human embryonic stem cell lines from parthenogenetic blastocysts , 2007, Cell Research.

[116]  S. Antonarakis,et al.  Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 , 2013, EMBO molecular medicine.

[117]  N. Benvenisty,et al.  Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells , 2014, Nature.

[118]  P. Lai,et al.  N-butylidenephthalide Attenuates Alzheimer's Disease-Like Cytopathy in Down Syndrome Induced Pluripotent Stem Cell-Derived Neurons , 2015, Scientific Reports.

[119]  R. Jaenisch,et al.  Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells , 2014, Stem cell reports.

[120]  Alexander Meissner,et al.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells , 2015, Nature Methods.

[121]  R. Martinez,et al.  A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells , 2013, Molecular and Cellular Neuroscience.

[122]  R. Pedersen,et al.  Epigenetic status of human embryonic stem cells , 2005, Nature Genetics.

[123]  Elsa Vera,et al.  Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. , 2015, Cell stem cell.

[124]  D. Geiger,et al.  Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome. , 2014, Human molecular genetics.

[125]  N. Benvenisty,et al.  Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.

[126]  L. Petrucelli,et al.  Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.

[127]  H. Kim,et al.  A guide to genome engineering with programmable nucleases , 2014, Nature Reviews Genetics.

[128]  Hiroyuki Miyoshi,et al.  Self-formation of functional adenohypophysis in three-dimensional culture , 2011, Nature.

[129]  S. Mccarroll,et al.  Characterization of Bipolar Disorder Patient-Specific Induced Pluripotent Stem Cells from a Family Reveals Neurodevelopmental and mRNA Expression Abnormalities , 2014, Molecular Psychiatry.

[130]  Yufeng Shen,et al.  Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. , 2014, Cell stem cell.

[131]  S. Perlman,et al.  SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs , 2013, Nature Communications.

[132]  박찬영.  Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome , 2012 .

[133]  S. Mitalipov,et al.  Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer , 2013, Cell.

[134]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[135]  A. Blakemore,et al.  Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion. , 2014, Human molecular genetics.

[136]  Stormy J. Chamberlain,et al.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes , 2010, Proceedings of the National Academy of Sciences.

[137]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[138]  C. Blackstone,et al.  Loss of Spastin Function Results in Disease‐Specific Axonal Defects in Human Pluripotent Stem Cell‐Based Models of Hereditary Spastic Paraplegia , 2014, Stem cells.

[139]  N. Benvenisty,et al.  Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells , 2014, Stem cell reports.

[140]  David G Hendrickson,et al.  Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy. , 2015, Cell stem cell.

[141]  Divya Rajamohan,et al.  Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation , 2011, European Heart Journal.

[142]  S. Tsang,et al.  Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. , 2014, Human molecular genetics.

[143]  J. Mertens,et al.  Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease , 2011, Nature.

[144]  L. Studer,et al.  Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells , 2012, Nature Biotechnology.

[145]  Christine Klein,et al.  Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.

[146]  Peter Reinhardt,et al.  Investigating human disease using stem cell models , 2014, Nature Reviews Genetics.

[147]  James Briggs,et al.  Integration‐Free Induced Pluripotent Stem Cells Model Genetic and Neural Developmental Features of Down Syndrome Etiology , 2013, Stem cells.

[148]  Andrew P. Feinberg,et al.  Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.